Themis Medicare is an API and finished-dose manufacturer based in India. It holds one active US drug master file. Its filings concentrate with FDA (GH), NAFDAC (NG) and TMDA (TZ). Its GMP standing is certified by NAFDAC (NG), EMA and FDA (GH), among 6 authorities. Customs aggregates show $11.6M of exports covering 166 molecules to 25 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Haridwar, India | Not on file |
| d c industrial estatevapi 396 195valsad, India | Not on file |
| Haridwar, Nigeria | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Simvastatin | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| FDA (GH) | 14 | 1 |
| NAFDAC (NG) | 14 | 3 |
| TMDA (TZ) | 1 | 1 |
| MINSA (CR) | 1 | None |
| EMA | None | 1 |
| CDSCO (India) | None | 1 |
| EAEU_EEC | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $1.2M | 11 |
| 2025 | Not reported | $11.6M | 25 |
| 2024 | Not reported | $8.3M | 22 |
| 2023 | Not reported | $20.4M | 21 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Themis Medicare comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.